COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization

Virginia Leiro-Fernandez (Vigo (Pontevedra), Spain), Virginia Leiro-Fernandez, Isaura Parente-Lamelas, Cristina Represas-Represas, Jose Abal- Arca, Esmeralda García-Rodriguez, Ana Priegue-Carrera, Cristina Ramos-Hernández, Cecilia Mouronte-Roibás, Maribel Botana-Rial, Alberto Fernández-Villar

Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Session: Epidemiology and specific subgroups in lung cancer
Session type: Thematic Poster
Number: 2792
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Virginia Leiro-Fernandez (Vigo (Pontevedra), Spain), Virginia Leiro-Fernandez, Isaura Parente-Lamelas, Cristina Represas-Represas, Jose Abal- Arca, Esmeralda García-Rodriguez, Ana Priegue-Carrera, Cristina Ramos-Hernández, Cecilia Mouronte-Roibás, Maribel Botana-Rial, Alberto Fernández-Villar. COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization. Eur Respir J 2016; 48: Suppl. 60, 2792

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014


Incidence of lung cancer in smokers with and without COPD: Observational study
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013


Incidence and clinical characteristics of lung cancer in patients with COPD - From Hokkaido COPD cohort study
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016



The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference?
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013


COPD; IPF; lung cancer in same individual: Can it be called 'AJMERITES SYNDROME?
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013

Increased sirtuin expression in patient with lung squamous cell carcinoma co-morbid with COPD
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015

Lung cancer in patient with chronic obstructive pulmonary disease (comorbidity by smokers-a cumulative effect of exogenic and endogenic factors? Part II)
Source: Annual Congress 2013 –COPD treatment
Year: 2013

Psychological assessment in COPD and lung cancer patients in pulmonary rehabilitation
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015

Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Chronic obstructive pulmonary disease as a predictor of lung cancer mortality
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers
Source: International Congress 2014 – Markers
Year: 2014

Lobectomy at patients with lung cancer and a chronic obstructive pulmonary disease as analogue of lung volume reduction surgery in COPD patients: To do or not to do?
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013

Lower rate of COPD exacerbations in patients with COPD and concurrent lung carcinoma – Data from the Bergmannsheil cohort
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015

Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015

Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013


Endoplasmic reticulum stress in bronchial tissue in patients with COPD and lung cancer
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Australia-modified Karnofsky performance scale in patients with COPD and lung cancer patients: A pooled data analysis
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016


Lung function in never smoking patients with alpha1antitrypsin deficiency
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013